BRYAN/COLLEGE STATION, Texas, April 25, 2011 /PRNewswire/ -- Caliber Biotherapeutics, a fully-integrated biopharmaceutical company, announced the opening of the world's largest plant-made pharmaceutical manufacturing facility in Bryan, Texas, with the capability of producing 10-100 million doses of infectious vaccines per month, and hundreds of thousands of doses of protein biotherapeutics such as monoclonal antibodies.
In addition to its plant-based facility, Caliber will also develop a proprietary product pipeline for cancer and infectious diseases utilizing cell- and microbial-based production systems. The end result will be new, more effective and affordable vaccines and biotherapeutics for patients – delivered in a time frame in which they are needed.
Led by physician-scientist and biodefense expert, Brett Giroir, M.D., and Barry Holtz, Ph.D., an internationally recognized pioneer in plant-made pharmaceuticals, Caliber Biotherapeutics represents a fundamentally different approach to vaccine and drug development.
"With plant-based systems, we have an unprecedented level of flexibility and scalability," said Dr. Holtz, Caliber's Chief Scientific Officer. "This enables simultaneous production of multiple proteins and rapid change-overs from one product to another in order to meet patients' needs and respond to emerging infectious diseases and bioterror threats."
"The Caliber platform is designed to be uniquely agile and responsive, enabling us to accelerate development of products with improved efficacy, reduced cost and enhanced safety," said Dr. Giroir, Chief Medical Officer. "Our goal is to make a rapid, meaningful impact on patients with unmet medical needs, both in the United States as well as in lesser developed countries with profound public health challenges."
In the coming months, Caliber will be announcing new major strategic alliances and its priorities for product development.
About Caliber Biotherapeutics
Caliber Biotherapeutics is a fully integrated biopharmaceutical company dedicated to creating greater and faster access to protein therapeutics and vaccines for cancer, infectious and orphan diseases. The company leverages highly agile, modular production technology and plant-, cell-, and microbial-based systems capable of accelerating delivery of novel treatments with increased efficacy and safety
Headquartered in Bryan / College Station, Texas, Caliber Biotherapeutics has assembled a world-class team of experts and established the world's largest plant-made pharmaceuticals facility that uniquely responds to changing demands and scale requirements. For more information, please visit the company's website at www.caliberbio.com
|SOURCE Caliber Biotherapeutics|
Copyright©2010 PR Newswire.
All rights reserved